Baptist Memorial Hospital-Memphis is a 706-bed medical facility in Memphis, Tennessee. This hospital, built in 1979, is now the flagship of Baptist Memorial Health Care since the closure of the Madison Campus in the Medical District, Memphis in 2000, which dated from 1912.

There are 706 beds in Baptist Memorial Hospital.

During the past decade, Baptist Memorial Hospital conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 26 clinical trials were completed, i.e. on average, 89.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 17 clinical trials were completed. i.e. 188.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baptist Memorial Hospital" #1 sponsor was "Abbott Medical Devices" with 10 trials, followed by "Edwards Lifesciences" with 6 trials sponsored, "Medtronic Cardiovascular" with 6 trials sponsored, "Boston Scientific Corporation" with 5 trials sponsored and "Alexion" with 5 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 36 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baptist Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "Patient-Centered Outcomes Research Institute" with 2 trials as a collaborator, "Thoratec Corporation" with 2 trials as a collaborator and "University of Alabama at Birmingham" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Baptist Memorial Hospital" are "Coronary Artery Disease" (5 trials), "Aortic Stenosis" (3 trials), "Heart Failure" (3 trials), "Stroke" (3 trials) and "Abdominal Aortic Aneurysms" (2 trials). Many other conditions were trialed in "Baptist Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Baptist Memorial Hospital" are "Device" (46 trials), "Drug" (15 trials), "Procedure" (10 trials), "Other" (6 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Numeris®-AF Guided Coagulation System with VisiTrax®" (2 trials), "TAVR Implantation with SAPIEN XT" (2 trials), "(LMW)heparin" (1 trials) and "3 months of dual antiplatelet therapy (DAPT)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baptist Memorial Hospital" are 62 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Baptist Memorial Hospital". undefined are not yet recruiting, 8 are recruiting, 6 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 40 completed trials in Baptist Memorial Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Baptist Memorial Hospital, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 41 trials that are defined as “Not Applicable".